Vilket är priset för PharmaSGP Holding SE (PSG)

Priset för PharmaSGP Holding SE (PSG) är $34.40

Vilket är marknadsvärdet för PharmaSGP Holding SE (PSG)

Marknadsvärdet för PharmaSGP Holding SE (PSG) är $396.01M

PharmaSGP Holding SE (PSG) Vinst

Founded in 2012 and based in Gräfelfing, Germany, PharmaSGP Holding SE specializes in the production of over-the-counter (OTC) pharmaceuticals and diverse healthcare goods. The company offers an extensive portfolio of products addressing various health concerns. This includes Baldriparan for sleep disturbances; pain relief solutions like Spalt, Formigran, and Kamol massage cream; RubaXX, specifically designed for rheumatic pain in bones, tendons, and muscles; and Restaxil, which targets nerve pain in the neck and back. Furthermore, their offerings encompass Fulminan, a beauty beverage for areas such as the eyes, buttocks, and thighs; DESEO drops for sexual weakness; Neradin, a medication for sexual dysfunction; and TAUMEA, aimed at managing vertigo. PharmaSGP also develops treatments for chronic conditions, including persistent pain and other age-associated ailments. Its products reach consumers via pharmacies and wholesalers, and are exported to several European nations, including Austria, Italy, Belgium, Spain, and France.

År	Vinst	Ändra
Inte tillräckligt med data för de angivna datumen.

År

Vinst

Ändra

Inte tillräckligt med data för de angivna datumen.

Företag	Vinst	Skillnad i vinst	Land
MERCK Kommanditgesellschaft auf Aktien MER.SW	-	-	DE
Merck KGaA MRK.DE	-	-	DE
Takeda Pharmaceutical Company Limited 4502.T	-	-	JP
Sun Pharmaceutical Industries Limited SUNPHARMA.NS	$1.76B	-	IN
Galderma Group AG GALD.SW	-	-	CH

Företag

Vinst

Skillnad i vinst

Land